Journals / Turkish Neurosurgery / 2017 / Cilt: 27 - Sayı: 5

The Effect of Intravenous L-Carnitine on the Vasospasm Process in the Experimental Subarachnoid Hemorrhage Model

Pages
751–755
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: L-carnitine was shown to be potentially beneficial on the resolution of cerebral vasospasm following SAH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Cerebral vasospasm after subarachnoid hemorrhage (SAH) is an important cause of morbidity and mortality.
📊
Key Findings & Data:MATERIAL and METHODS: Twenty male New Zealand white rabbits were randomly divided into 4 groups.
💡
Conclusion & Impact:CONCLUSION: L-carnitine was shown to be potentially beneficial on the resolution of cerebral vasospasm following SAH.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: Cerebral vasospasm after subarachnoid hemorrhage (SAH) is an important cause of morbidity and mortality. In this study, we examined the effects of L-carnitine on the cerebral vasospasm process. MATERIAL and METHODS: Twenty male New Zealand white rabbits were randomly divided into 4 groups. Group 1 served as control; group 2 was not subjected to SAH and received intravenous L-carnitine 3 times; group 3 was subjected to SAH and group 4 was subjected to SAH and treated with 100 mg/kg intravenous L-carnitine at 0, 24, and 48 hours after SAH. All animals were euthanized by perfusion-fixation 72 hours after SAH induction. The brains were then removed and stored in fixative +4°C overnight. The subjects' basilar arteries were sectioned from four separate zones. Basilar artery cross-sectional areas and thicknesses of vessels were measured by using the SPOT for Windows Version 4.1 computer programme. Statistical comparisons were performed by using the Kruskal-Wallis and Mann-Whitney U tests. RESULTS: Basilar artery wall thicknesses in group 4 were significantly lower than in group 3 (p=0.009). Basilar artery cross-sectional areas in group 4 were higher than in group 3 and the difference was statistically significant (p=0.008). CONCLUSION: L-carnitine was shown to be potentially beneficial on the resolution of cerebral vasospasm following SAH.

🔖

Cite This Article

SOYER, A., GOKTEN, M., ÖGE, H. K., SÖYLEMEZOĞLU, F. (2017). The Effect of Intravenous L-Carnitine on the Vasospasm Process in the Experimental Subarachnoid Hemorrhage Model. Turkish Neurosurgery, Cilt: 27 - Sayı: 5, 751–755. https://ajindex.com/articles/417814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Asano T: Oxyhemoglobin as the principal cause of cerebral vasospasm: A holistic view of its actions. Crit Rev Neurosurg 9(5): 303-318, 1999 2. Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N: Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 59(5): 1102-1108, 2006 3. Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi F: Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: A randomized, double-blind placebocontrolled clinical trial. J Clin Endocrinol Metab 86(8): 3579- 3594, 2001 4. Carrero JJ, Grimble RF: Does nutrition have a role in peripheral vascular disease? Br J Nutr 95(2): 217-229, 2006 5. Cavallini G, Modenini F, Vitali G, Koverech A: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. Urology 66(5): 1080-1085, 2005 6. Crowley RW, Medel R, Kassell NF, Dumont AS: New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage. Drug Discov Today 13(5-6): 254- 260, 2008 7. DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH: L-carnitine in the secondary prevention of cardiovascular disease: Systematic review and meta-analysis. Mayo Clin Proc 88(6): 544-551, 2013 8. Dusick JR, Gonzalez NR: Management of arterial vasospasm following aneurysmal subarachnoid hemorrhage. Semin Neurol 33(5): 488-497, 2013 9. Ecker A, Riemenschneider PA: Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. J Neurosurg 8(6): 660-667, 1951 10. Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F: Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. AJNR Am J Neuroradiol 26(6): 1357-1362, 2005 11. Gulcin I: Antioxidant and antiradical activities of L-carnitine. Life Sci 78(8): 803-811, 2006 12. Head KA: Peripheral neuropathy: Pathogenic mechanisms and alternative therapies. Altern Med Rev 11(4): 294-329, 2006 13. Kolias AG, Sen J, Belli A: Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Putative mechanism and novel approaches. J Neurosci Res 87(1): 1-11, 2009 14. Pettegrew JW, Levine J, McClure RJ: Acetyl-L-carnitine physical-chemical, metab